Viewing nowMontelukast Chewable Tablets 5 mg (Montelukast Sodium)
Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

MFDS item code 201500942 · Approved 2015.02.24 · Insurance code 645208650
Prevention and treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
This medicine helps to prevent and manage asthma continuously. It also alleviates symptoms of seasonal and perennial allergic rhinitis, improving respiratory health. It is used for the treatment of asthma and allergic rhinitis.
This medicine is taken once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the administration time should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. Adults and adolescents aged 15 years and older: Administer montelukast 10 mg orally once daily. Adults and adolescents aged 15 years and older: Place montelukast 10 mg on the tongue once daily and allow it to dissolve; take without water.
Children aged 6~14 years: Chew montelukast 5 mg once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Chew montelukast 4 mg once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place montelukast 5 mg on the tongue once daily and take without water once it disintegrates. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place montelukast 4 mg on the tongue once daily and take without water once it disintegrates. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place montelukast 5 mg on the tongue once daily and allow it to dissolve; take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place montelukast 4 mg on the tongue once daily and allow it to dissolve; take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Administer montelukast 5mg orally once daily. Administer this medicine 1 hour before or 2 hours after a meal. Asthma - Children aged 2~5 years: Administer montelukast 4 mg orally once daily. Asthma - Infants aged 12 months~under 2 years: Administer this medicine 4 mg orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months. Allergic rhinitis - Children aged 2~5 years: Administer montelukast 4 mg orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years. Allergic rhinitis - Infants aged 6 months~under 2 years: Administer this medicine 4mg orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months.
This medication contains the artificial sweetener aspartame, which is broken down in the body into phenylalanine. Therefore, it is advisable for patients with the hereditary condition phenylketonuria not to take this medication. The acceptable daily intake of aspartame is limited to less than 40 mg per kg of body weight, so caution is required during use. Due to the lactose component contained in this medication, patients with genetic issues such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take it. This medication is not a treatment for acute asthma attacks, so appropriate emergency medication should be used when acute symptoms occur. Side effects such as fatigue, headache, dyspepsia, rash, nasal congestion, and cough may occur; consult a doctor if symptoms worsen. Particularly rare but serious symptoms such as systemic eosinophilia and vasculitis may occur, so if symptoms of eosinophilia or pulmonary symptoms worsen, immediate notification to medical personnel is necessary. Patients who have hypersensitivity reactions to aspirin or non-steroidal anti-inflammatory drugs should avoid these medications while taking this drug. This medication should only be administered during pregnancy when necessary, and breastfeeding individuals should be cautioned. Children and the elderly can also take it; however, dosage and administration methods should be adjusted according to age, and safety has not been established in infants under 6 months. There is no specific antidote for overdose, so it is important to receive general treatment, such as removing the medication from the gastrointestinal tract. This medication is sensitive to light, so it is advisable to open it just before taking it and consume it immediately. Store in a place out of reach of children, and do not transfer to another container, which helps maintain the safety and quality of the drug. This medication should be taken continuously as directed by the physician, even when there are no symptoms of asthma or allergic rhinitis, as it helps to prevent symptoms. If neuropsychiatric symptoms occur during treatment, immediate consultation with a physician is necessary.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to moisture and light, so it should be stored at room temperature between 1°C and 30°C. It should also be kept in a tightly closed container to prevent air exposure.
Pink chewable tablet with a convex surface on both sides
28 tablets/PTP (7 tablets/PTP x 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.